The Evaluation of Benzodiazepine Substances and Other Depressants, Drug Discrimination Assay

This RFQ Amendment No. 0001 is issued to establish be following:
1) DEA Q& A response to Vendor(s) questions.
2) Revision of the RFQ in accordance with DEA Q&A response. Note, all changes are cited in RED.
3) Revision of the Attachment 1 - Pricing Sheet Template. Note, all changes are cited in RED.
4) The hour and date for receipt of Offers/Quotations is extended to October 20, 2023 at 10:00 A.M.